• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JXSL2300157 Faricimab注射液 faricimab Injection Biological Products(2.2) Import Drug Application 2023-08-19 view
JXSS2200032 Faricimab注射液 faricimab Injection Biological Products(3.1) Import Drug Application 2022-08-12 view
JXSS2200030 Faricimab注射液 faricimab Injection Biological Products(3.1) Import Drug Application 2022-08-04 view
JXSL2200038 Faricimab注射液 faricimab Injection Biological Products(2.2) Import Drug Application 2022-03-24 view
JXSB2101076 Faricimab注射液 faricimab Injection Biological Products(1) Supplementary Application 2021-10-26 view
JXSL2100010 Faricimab注射液 faricimab Injection Biological Products(1) Import Drug Application 2021-01-25 罗氏(中国)投资有限公司 Roche (China) Holding Ltd In Review 2021-01-25 view
JXSL2000076 Faricimab注射液 faricimab Injection Biological Products Import Drug Application 2020-06-13 罗氏(中国)投资有限公司 Roche (China) Holding Ltd In Review 2020-06-12 view
JXSL2000077 Faricimab注射液 faricimab Injection Biological Products Import Drug Application 2020-06-13 罗氏(中国)投资有限公司 Roche (China) Holding Ltd In Review 2020-06-12 view
JXSL1900020 Faricimab注射液 faricimab Injection Biological Products Import Drug Application 2019-02-27 罗氏(中国)投资有限公司 Roche (China) Holding Ltd In Review 2019-02-26 view
JXSL1900011 Faricimab注射液 faricimab Injection Biological Products Import Drug Application 2019-02-20 罗氏(中国)投资有限公司 Roche (China) Holding Ltd In Review 2019-02-19 view